Avecho Biotechnology Ltd has released a press release.
June 2025 Quarterly Activities Report & Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Story so far
Earlier from Avecho Biotechnology
- Phase III Insomnia Trial Recruitment Update
- Receipt of R&D Tax Incentive
- Phase III Trial Update - New Sites Commence Recruitment
- March 2025 Quarterly Activities Report & Appendix 4C
- Avecho receives initial US$3M upfront payment from Sandoz
Later from Avecho Biotechnology
- Sleep Health Week: Researchers Recruiting Now for CBD Insomnia Trial
- Appendix 4D and Half-year Financial Report
- Avecho raises $2.5m via placement
- September 2025 Quarterly Activities Report & Appendix 4C
- AVE Secures US & EU Patent Allowances for CBD Soft-Gel
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology